CE Activities

Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education
Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education
CME, CPE, CNE
Beth Faiman, PhD, CNP; Heidi D. Finnes, PharmD, BCOP; Jeffrey Jones, MD
Release Date: January 17, 2017
Expiration Date: January 17, 2018

In this activity, participants will learn about key risk-stratification strategies and associated treatment pathways for patients with CLL. Aspects of care that are critical to specific disciplines will also be discussed, such as concomitant medications for pharmacists and patient monitoring for nurses. In addition, participants will gain an understanding of the role of shared decision-making and communication strategies to engage their patients with CLL.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Genentech

Begin, Earn CreditView Only, No Credit
 
Empowering Community Oncologists in the New Era of Cancer Management: ADAPTATION OF THE IMMUNO-ONCOLOGY REGIONAL MEETING SERIES
Empowering Community Oncologists in the New Era of Cancer Management: ADAPTATION OF THE IMMUNO-ONCOLOGY REGIONAL MEETING SERIES
CME, CPE, CNE
Bradley C. Carthon, MD, PhD; Jason J. Luke, MD, FACP; Jeffrey S. Weber, MD, PhD
Release Date: May 07, 2015
Expiration Date: May 07, 2016
Drs. Carthon, Luke, and Weber discuss the growth of new science in immuno-oncology, guideline updates, and advances to better understand and apply these new options in community practice.

Provided by MediCom Worldwide, Inc.

This activity is supported by educational grants from AstraZeneca, Bristol-Myers Squibb, Genentech, and Prometheus Therapeutics & Diagnostics

View Only, CE ExpiredView Only, No Credit
 
Individualizing Therapeutic Options and Achieving Goals in Chronic Lymphocytic Leukemia (CLL)
Individualizing Therapeutic Options and Achieving Goals in Chronic Lymphocytic Leukemia (CLL)
CME
Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD; Peter Hillmen, MD, FRCP, FRCPath, PhD; Thomas J. Kipps, MD
Release Date: March 17, 2015
Expiration Date: March 17, 2016
Drs. Burger, Brown, Hillmen, and Kipps discuss critical information, expert guidelines, and recommendations concerning evolving treatment paradigms in chronic lymphocytic leukemia (CLL) as well as address current clinical controversies. This accredited activity presents the most up-to-date data, recommendations, and practice standards in order to help participants gain additional knowledge and understanding required to assess all possible therapeutic strategies for patients with CLL.

Provided by MediCom Worldwide, Inc. and The University of Texas MD Anderson Cancer Center

This activity has been supported by educational grants from Pharmacyclics, Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and from Teva Pharmaceuticals.

View Only, CE ExpiredView Only, No Credit